ZTS: Summary for Zoetis Inc. Class A - Yahoo Finance

UK Markets closed

Zoetis Inc. (ZTS)


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
56.11-0.35 (-0.62%)
At close: 4:01PM EDT
People also watch
MNKZBHIDXXPRGOXYL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close56.46
Open56.46
Bid56.00 x 100
Ask58.00 x 100
Day's range56.08 - 56.62
52-week range45.28 - 56.65
Volume3,341,793
Avg. volume3,389,412
Market cap27.59B
Beta1.22
PE ratio (TTM)34.01
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield0.42 (0.76%)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Business Wire3 days ago

    Zoetis Receives European Commission Marketing Authorization for Cytopoint® (lokivetmab)

    ZAVENTEM, Belgium--(BUSINESSWIRE)-- The first monoclonal antibody authorized for veterinary use in the European Union A single injection of Cytopoint treats the clinical signs of atopic dermatitis in dogs, ...

  • Zoetis Receives European Commission Marketing Authorization for Cytopoint® (lokivetmab)
    Business Wire3 days ago

    Zoetis Receives European Commission Marketing Authorization for Cytopoint® (lokivetmab)

    Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Cytopoint , the first monoclonal antibody therapy approved in the European Union for veterinary use.

  • Capital Cube8 days ago

    Zoetis, Inc. – Value Analysis (NYSE:ZTS) : April 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Zoetis, Inc. a score of 81. Our analysis is based on comparing Zoetis, Inc. with the following peers – Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Parnell Pharmaceuticals Holdings Ltd., Aratana Therapeutics, Inc., Heska Corporation, ImmuCell Corporation, Sanofi Sponsored ADR, Phibro Animal Health Corporation ... Read more (Read more...)